ALVO
Price
$8.33
Change
+$0.29 (+3.61%)
Updated
Sep 5 closing price
Capitalization
2.6B
67 days until earnings call
PBH
Price
$65.05
Change
-$1.70 (-2.55%)
Updated
Sep 5 closing price
Capitalization
3.2B
54 days until earnings call
Interact to see
Advertisement

ALVO vs PBH

Header iconALVO vs PBH Comparison
Open Charts ALVO vs PBHBanner chart's image
Alvotech
Price$8.33
Change+$0.29 (+3.61%)
Volume$448.25K
Capitalization2.6B
Prestige Consumer Healthcare
Price$65.05
Change-$1.70 (-2.55%)
Volume$693.52K
Capitalization3.2B
ALVO vs PBH Comparison Chart in %
Loading...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVO vs. PBH commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and PBH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ALVO: $8.33 vs. PBH: $65.05)
Brand notoriety: ALVO and PBH are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALVO: 112% vs. PBH: 133%
Market capitalization -- ALVO: $2.6B vs. PBH: $3.2B
ALVO [@Pharmaceuticals: Generic] is valued at $2.6B. PBH’s [@Pharmaceuticals: Generic] market capitalization is $3.2B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green whilePBH’s FA Score has 0 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • PBH’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALVO and PBH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 3 TA indicator(s) are bullish while PBH’s TA Score has 3 bullish TA indicator(s).

  • ALVO’s TA Score: 3 bullish, 2 bearish.
  • PBH’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALVO is a better buy in the short-term than PBH.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а +3.22% price change this week, while PBH (@Pharmaceuticals: Generic) price change was -4.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ALVO is expected to report earnings on Nov 12, 2025.

PBH is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBH($3.2B) has a higher market cap than ALVO($2.6B). ALVO has higher P/E ratio than PBH: ALVO (36.22) vs PBH (15.27). PBH YTD gains are higher at: -16.699 vs. ALVO (-37.037). PBH has higher annual earnings (EBITDA): 362M vs. ALVO (207M). ALVO has more cash in the bank: 151M vs. PBH (140M). PBH has less debt than ALVO: PBH (1.04B) vs ALVO (1.27B). PBH has higher revenues than ALVO: PBH (1.12B) vs ALVO (560M).
ALVOPBHALVO / PBH
Capitalization2.6B3.2B81%
EBITDA207M362M57%
Gain YTD-37.037-16.699222%
P/E Ratio36.2215.27237%
Revenue560M1.12B50%
Total Cash151M140M108%
Total Debt1.27B1.04B122%
FUNDAMENTALS RATINGS
PBH: Fundamental Ratings
PBH
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
62
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
72
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVOPBH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
57%
Momentum
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
52%
MACD
ODDS (%)
Bullish Trend 1 day ago
45%
Bullish Trend 1 day ago
55%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
53%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
45%
Advances
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 9 days ago
57%
Declines
ODDS (%)
Bearish Trend 11 days ago
68%
Bearish Trend 1 day ago
52%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
57%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PBH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRSIX26.86N/A
N/A
MFS Research International I
JERIX12.27N/A
N/A
Janus Henderson Global Real Estate I
WFGGX31.08N/A
N/A
First Trust WCM Focused Global Gr Inv
IGISX20.57N/A
N/A
Voya Growth and Income Port S2
HRLSX9.58N/A
N/A
Hartford Real Asset R4

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+3.61%
EBS - ALVO
27%
Poorly correlated
-0.66%
CRON - ALVO
23%
Poorly correlated
N/A
ACB - ALVO
22%
Poorly correlated
+1.66%
PAHC - ALVO
22%
Poorly correlated
+0.97%
PBH - ALVO
21%
Poorly correlated
-2.55%
More